Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Singer

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Frontiers in Oncology|November 17, 2022
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinomaLinus D Kloker, Branko Calukovic, Katrin Benzler, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Molecular & Cellular Proteomics : MCP|July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded TissueVanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2025
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive SubtypesDavid J Papke, John S A Chrisinger, Christopher A French, et al.
Gastroenterology|February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaDarjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Gastroenterology|March 3, 2017
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver CancerSofia M E Weiler, Federico Pinna, Thomas Wolf, et al.
Neuro-Oncology Advances|March 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohortDavid Rieger, Hannes Becker, Bianca Walter, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Frontiers in Oncology|November 17, 2022
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinomaLinus D Kloker, Branko Calukovic, Katrin Benzler, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Molecular & Cellular Proteomics : MCP|July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded TissueVanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2025
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive SubtypesDavid J Papke, John S A Chrisinger, Christopher A French, et al.
Gastroenterology|February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaDarjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Gastroenterology|March 3, 2017
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver CancerSofia M E Weiler, Federico Pinna, Thomas Wolf, et al.
Neuro-Oncology Advances|March 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohortDavid Rieger, Hannes Becker, Bianca Walter, et al.
Pageof 10